Health Care Sector Update for 07/08/2019: PRVL,SGMO,ITCI



Shutterstock photo

Top Health Care Stocks

JNJ +0.06%

PFE -1.79%

ABT -0.44%

MRK -2.3%

AMGN -2.58%

Health care stocks retreated Monday, with the NYSE Health Care Index sinking nearly 0.8% while the shares of health care companies in the S&P 500 also were down 1% as a group. The Nasdaq Biotechnology index was falling 1.8%.

Among health care stocks moving on news:

(+) Prevail Therapeutics ( PRVL ) rose 7.7% after saying the US Food and Drug Administration has designated its PR001 lead gene therapy program for fast-track development and review as a potential treatment of Parkinson’s disease in patients with a mutation of the GBA1 gene. The company is expecting to begin dosing patients in a phase 1/2 trial of PR001 later this year.

In other sector news:

(+) Sangamo Therapeutics ( SGMO ) surged 8.5% on Monday after the genomic medicine company and Pfizer ( PFE ) late Friday said their SB-525 experimental gene therapy for hemophilia A demonstrated promising results during phase 1/2 testing. The prospective treatment for patients with the bleeding disorder was largely well-tolerated and also showed a dose-dependent increase in Factor VIII clotting activity.

(-) Intra-Cellular Therapies ( ITCI ) dropped over 21% after reporting mixed results from a late-stage study of its lumateperone drug candidate, with the prospective treatment for bipolar depression meeting its primary endpoint during one phase III trial but failing to produce a statistically significant improvement in depression symptoms during a second round of testing.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


















Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.

Wealth Empire Newsletter
Register now for free updates and alerts

Subscribe By

Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.